Oxford vaccine team wins £1.4m to develop jab against ‘super gonorrhoea’
The Oxford University institute behind the AstraZeneca Covid vaccine has been awarded $2 million (£1.4m) to develop a jab against the increasing threat of “super gonorrhoea”.
Researchers at the Jenner Institute believe their vaccine, one of just a handful currently in development, will prevent infections from different strains of the sexually transmitted infection (STI), including the most powerful multi-drug resistant forms that are spreading around the world.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!